Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling

Magnetic Resonance Imaging

Volumn 18, Issue 5, 2000, Pages 525-535

  Egmont Petersen, Michael ^a   Hogendoorn, Pancras C W ^a   Van Der Geest, Rob J ^a   Vrooman, Henri A ^a   Van Der Woude, Henk Jan ^a   Janssen, Jasper P ^a   Bloem, Johan L ^a   Reiber, Johan H C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone neoplasms; Ewing's sarcoma; Local arrival time; Pharmacokinetics; Registration; Segmentation; Two compartment model; Validation

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEMBRANE PERMEABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR VOLUME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; NEOPLASM, RESIDUAL; SARCOMA, EWING'S;

EID: 0033920502     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(00)00144-2     Document Type: Article

References (22)

1. Egmont-Petersen M., Pelikan E. Detection of bone tumours in radiographs using neural networks. Pattern Anal Appl. 2:1999;172-183.
2. Bloem J.L., van der Woude H.J., Geirnaerdt M., Hogendoorn P.C., Taminiau A.H., Hermans J. Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma? Br J Radiol. 70:1997;327-337.
3. van der Woude H.J., Verstraete K.L., Hogendoorn P.C.W., Taminiau A.H.M., Hermans J., Bloem J.L. Musculoskeletal Tumors does fast dynamic contrast-enhanced subtraction MR Imaging contribute to the characterization? Radiology. 208:1998;821-828.
4. Kroon H.M., Bloem J.L., Holscher H.C., van der Woude H.J., Reijnierse M., Taminiau A.H. MR imaging of edema accompanying benign and malignant bone tumors. Skeletal Radiol. 23:1994;261-269.
5. van der Woude H.J., Bloem J.L., Verstraete K.L., Taminiau A.H., Nooy M.A., Hogendoorn P.C. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy value of dynamic MR imaging in detecting viable tumor before surgery . Am J Roentgenol. 165:1995;593-598.
6. van der Woude H.J., Bloem J.L., Holscher H.C., Nooy M.A., Taminiau A.H., Hermans J., Falke T.H., Hogendoorn P.C. Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging. Skeletal Radiol. 23:1994;493-500.
7. Tofts P.S., Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 17:1991;357-367.
8. Jürgens H, Dunst J, Göbel U, et al. Improved survival in Ewing's sarcoma with response based on local therapy and intensive chemotherapy. Proc Am Soc Clin Oncol 1991. p 316.
9. van der Woude H.J., Bloem J.L., Taminiau A.H., Nooy M.A., Hogendoorn P.C. Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol. 23:1994;501-507.
10. Blombergen N. Proton relaxation times in paramagnetic solutions. J Chem Phys. 27:1957;572-573.
11. Hoffmann U., Brix G., Knopp M.V., Hess T., Lorenz W.J. Pharmacokinetic mapping of the breast a new method for dynamic MR mammography . Magn Reson Med. 33:1995;506-514.
12. Gullberg G.T., Ma X., Parker D.L., Ghosh Roy D.N. An MRI perfusion model incorporating nonequilibrium exchange between vascular and extravascular components. Magn Reson Imaging. 9:1991;39-52.
13. Rowland M., Tozer T.N. Clinical pharmacokinetics. 1995;Williams & Wilkins, Baltimore.
14. Meyer E. Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the (H2O)-O-15 autoradiographic method and dynamic PET. J Nucl Med. 30:1989;1069-1078.
15. van der Woude H.J., Bloem J.L., Taminiau A.H., Nooy M.A., Hogendoorn P.C. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy the utility of sequential color Doppler sonography in predicting histopathologic response . Am J Roentgenol. 165:1995;125-133.
16. Press W.H., Teukolsky S.A., Vetterling W.T., Flannery B.P. Numerical recipes in C. 1992;Cambridge University Press, Cambridge.
17. Egmont-Petersen M., Talmon J.L., Brender J., McNair P. On the quality of neural net classifiers. Artificial Intelligence Med. 6:1994;359-381.
18. DeBaere T., Vanel D., Shapeero L.G., Charpentier A., Terrier P., DiPaola M. Osteosarcoma after chemotherapy - Evaluation with contrast material enhanced subtraction MR Imaging. Radiology. 185:1992;587-592.
19. Wikstrom M.G., Moseley M.E., White D.L., Dupon J.W., Winkelhake J.L., Kopplin J., Brasch R.C. Contrast-enhanced MRI of tumors - Comparison of Gd-DTPA and a macromolecular agent. Invest Radiol. 24:1989;609-615.
20. Lyng H., Dahle G.A., Kaalhus O., Skretting A., Rofstad E.K. Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging. Magn Reson Med. 40:1998;89-98.
21. Boas M.L. Mathematical methods in the physical sciences. 1983;John Wiley & Sons, New York.
22. Tofts P.S., Berkowitz B., Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med. 33:1995;564-568.